sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Spire Healthcare
The Vanguard Group, Inc. has disclosed its position in Spire Healthcare Group plc under Form 8.3, adhering to Rule 8.3 of the Takeover Code. The disclosure, dated 10 December 2025, reveals that Vanguard holds interests representing 3.58% in Spire Healthcare's 1p ordinary shares, totaling 14,403,944 shares.
The filing notes that Transaction activity on 9 December 2025 included a purchase of 5,835 shares at 1.67 GBP per unit. No further positions in cash-settled or stock-settled derivatives have been reported, and Vanguard states no significant agreements or inducements related to Spire's securities.
No other parties are involved in the disclosure, and there are no supplemental attachments. Vanguard maintains no related agreements concerning securities voting rights or future transactions. Contact for this disclosure is Shawn Acker at +001-610-669-6713.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.